Sirolimus Eluting Coronary Stent System
| Min. Order: | 50 Set/Sets |
|---|---|
| Payment Terms: | T/T, WU |
| Supply Ability: | 80000 set per month |
| Place of Origin: | Guangdong |
Company Profile
| Location: | China (Mainland) |
|---|---|
| Business Type: | Manufacturer |
Product Detail
| Production Capacity: | 80000 set per month |
|---|---|
| Packing: | Carton Size: 27 x 25 x 31 CM 30/CTN |
| Delivery Date: | 20 days |
Product Description
Specifications: | |
Stent Plaform | 316L Stainless Steel |
Coating Material | PLGA (Biodegradable) |
Coating Thickness | 4.0±1.0μm |
Drug | Sirolimus (Rapamycine) |
Drug Content | 170μg/cm2±20μg/cm2 (12mm,18mm) |
150μg/cm2±20μg/cm2 (23mm,28mm,33mm) | |
Degradation Time | >2Months |
Clinical Results in 90 Patients with CTO: | ||
Control Group | Rapa | BMS |
6 Month MACE | 0% | 0% |
6 Month TVR | 11% | 55% |
6 Month TLR | 4% | 19% |
6 Month In-Stent Restenosis | 16% | 61% |
6 Month In-Stent Late loss | 0.41mm | 1.46mm |
| |||||||||
Length | 9 | 12 | 16 | 18 | 20 | 23 | 28 | 33 | |
Diameter | |||||||||
2.50 | √ | √ | √ | √ |
| √ |
|
| |
2.75 | √ | √ | √ | √ | √ | √ |
|
| |
3.00 | √ | √ | √ | √ | √ | √ | √ | √ | |
3.50 | √ | √ | √ | √ | √ | √ | √ | √ | |
4.00 | √ | √ | √ | √ | √ | √ | √ | √ | |
